Structures by: Abourahma H.
Total: 28
1,4,7,10,13-pentaoxacyclopentadecane ethanedithioamide clathrate
C10H20O5,C2H4N2S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=8.2660(5)Å b=8.6440(6)Å c=12.5320(10)Å
α=80.053(3)° β=81.737(3)° γ=75.392(3)°
Cis-syn-cis (A) isomer (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane bis(ethanedithioamide) clathrate
C20H36O6,2(C2H4N2S2)
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=23.72000(10)Å b=7.6550(2)Å c=18.3640(3)Å
α=90.0000° β=106.9810(6)° γ=90.0000°
1,4,7,10,13,16-hexaoxacyclooctadecane N,N'- (thiocarbamoyl)hydrazine clathrate
C12H24O6,C2H6N4S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=14.196(3)Å b=7.187(2)Å c=19.552(3)Å
α=90.00° β=92.18(2)° γ=90.00°
Cis-anti-cis (B) isomer (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane bis(ethanedithioamide) clathrate
C20H36O6,2(C2H4N2S2)
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=12.654(3)Å b=7.5700(15)Å c=17.129(3)Å
α=90.00° β=106.14(3)° γ=90.00°
Cis-anti-cis isomer (B) (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane N,N'-(thiocarbamoyl)hydrazine clathrate
C20H36O6,C2H6N4S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=12.489(2)Å b=7.509(2)Å c=14.639(3)Å
α=90.00° β=93.61(3)° γ=90.00°
1,4,7,10,13-pentaoxacyclopentadecane bis(N,N'- (thiocarbamoyl)hydrazine) clathrate
C10H20O5,2(C2H6N4S2)
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=13.632(3)Å b=9.475(2)Å c=19.185(4)Å
α=90.00° β=90.00° γ=90.00°
1,4,7,10-tetraoxacyclododecane N,N'-(thiocarbamoyl)hydrazine clathrate
C8H16O4,C2H6N4S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=18.475(4)Å b=18.445(4)Å c=9.443(2)Å
α=90.00° β=90.00(3)° γ=90.00°
C34H22N2O8Zn2
C34H22N2O8Zn2
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=30.2394(11)Å b=30.2394(11)Å c=18.2791(13)Å
α=90.00° β=90.00° γ=120.00°
C53.25H31Cu4N3O17
C53.25H31Cu4N3O17
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=10.6661(12)Å b=30.303(4)Å c=16.3650(19)Å
α=90.00° β=95.877(2)° γ=90.00°
C17H11CoNO6.48
C17H11CoNO6.48
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=30.3087(15)Å b=30.3087(15)Å c=18.3364(13)Å
α=90.00° β=90.00° γ=120.00°
C34H22Cu2N2O8
C34H22Cu2N2O8
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=30.337(2)Å b=30.337(2)Å c=18.380(2)Å
α=90.00° β=90.00° γ=120.00°
C200H72Cu24O206.4S4
C200H72Cu24O206.4S4
Chemical Communications (2001) 22 2380
a=31.111(4)Å b=31.111(4)Å c=35.999(6)Å
α=90.00° β=90.00° γ=90.00°
Theophylline-melamine
C12H20N10O3S
CrystEngComm (2012) 14, 19 6163
a=15.4964(11)Å b=8.8674(6)Å c=13.2985(9)Å
α=90.00° β=109.4230(10)° γ=90.00°
Anthranilic acid Pyrazinamide
C7H7NO2,C5H5N3O
CrystEngComm (2011) 13, 21 6442
a=7.2482(10)Å b=7.5827(10)Å c=12.2794(16)Å
α=77.826(2)° β=84.096(2)° γ=63.018(2)°
C34H22N2O8Zn2
C34H22N2O8Zn2
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=30.2394(11)Å b=30.2394(11)Å c=18.2791(13)Å
α=90.00° β=90.00° γ=120.00°
C53.25H31Cu4N3O17
C53.25H31Cu4N3O17
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=10.6661(12)Å b=30.303(4)Å c=16.3650(19)Å
α=90.00° β=95.877(2)° γ=90.00°
C17H11CoNO6.48
C17H11CoNO6.48
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=30.3087(15)Å b=30.3087(15)Å c=18.3364(13)Å
α=90.00° β=90.00° γ=120.00°
C34H22Cu2N2O8
C34H22Cu2N2O8
Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343
a=30.337(2)Å b=30.337(2)Å c=18.380(2)Å
α=90.00° β=90.00° γ=120.00°
2(Pyrazinamide).(4-nitrobenzoic acid)
C7H5NO4,2(C5H5N3O)
Crystal Growth & Design (2015) 15, 7 3101
a=3.6371(11)Å b=36.541(11)Å c=6.564(2)Å
α=90.00° β=94.998(3)° γ=90.00°
C25H24Cu2N4O9
C25H24Cu2N4O9
Crystal Growth & Design (2003) 3, 4 513
a=8.2043(13)Å b=14.970(2)Å c=10.6012(16)Å
α=90.00° β=90.191(3)° γ=90.00°
C18H10CuNO5
C18H10CuNO5
Crystal Growth & Design (2003) 3, 4 513
a=18.7912(8)Å b=18.7912(8)Å c=16.8886(10)Å
α=90.00° β=90.00° γ=90.00°
C22H16Cu2O10S4
C22H16Cu2O10S4
Crystal Growth & Design (2003) 3, 4 513
a=15.637(4)Å b=15.430(4)Å c=13.332(3)Å
α=90.00° β=116.692(4)° γ=90.00°
C26H26Cu2N4O9
C26H26Cu2N4O9
Crystal Growth & Design (2003) 3, 4 513
a=8.4851(15)Å b=14.639(2)Å c=11.1455(19)Å
α=90.00° β=93.392(3)° γ=90.00°
C30H28Cu2N2O12
C30H28Cu2N2O12
Crystal Growth & Design (2003) 3, 4 513
a=18.8743(16)Å b=18.8743(16)Å c=17.356(3)Å
α=90.00° β=90.00° γ=90.00°
C33H26Cu2N3O10.5
C33H26Cu2N3O10.5
Crystal Growth & Design (2003) 3, 4 513
a=10.2527(12)Å b=18.973(2)Å c=16.977(2)Å
α=90.00° β=100.460(2)° γ=90.00°
C24H38Cu2N2O20S4
C24H38Cu2N2O20S4
Journal of the American Chemical Society (2002) 124, 9990-9991
a=14.0608(12)Å b=13.8902(12)Å c=19.0465(16)Å
α=90.00° β=98.487(2)° γ=90.00°
C34H26Cl2Cu2N2O8
C34H26Cl2Cu2N2O8
Crystal Growth & Design (2003) 3, 4 513
a=19.5148(14)Å b=12.7678(9)Å c=14.3466(10)Å
α=90.00° β=114.1330(10)° γ=90.00°
C41H40CuN6O9S0.08
C41H40CuN6O9S0.08
Journal of the American Chemical Society (2002) 124, 9990-9991
a=35.023(4)Å b=35.023(4)Å c=9.9711(13)Å
α=90.00° β=90.00° γ=120.00°